{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:32:47Z","timestamp":1783780367639,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,16]]},"DOI":"10.7759\/cureus.12114","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T06:05:14Z","timestamp":1608185114000},"source":"Crossref","is-referenced-by-count":1,"title":["Filgrastim-Associated Pneumonitis in Cancer Patient Undergoing Hematopoietic Stem Cell (HSC) Mobilization for Autologous-HSC Transplantation"],"prefix":"10.7759","author":[{"given":"Drashti R","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashokakumar M","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470988763.ch17","article-title":"Hematopoietic stem cell transplantation- the future","author":"Khaddour K","unstructured":"Khaddour K, Hana CK, Mewawalla P. Hematopoietic stem cell transplantation- the future. Blackwell Publishing Ltd, 188-191. 10.1002\/9780470988763.ch17"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78580-6_2","article-title":"The principles and overview of autologous hematopoietic stem cell transplantation","author":"Vaughan W","year":"2009","unstructured":"Vaughan W, Seshadri T, Bridges M, Keating A. The principles and overview of autologous hematopoietic stem cell transplantation. Cancer Treat Res. Springer, Boston, MA; 2009. 144:23-45. 10.1007\/978-0-387-78580-6_2"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"33","author":"Smith TJ","year":"2015","unstructured":"Smith TJ, Bohlke K, Lyman GH, et al.. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015, 33:3199-3212.  10.1200\/JCO.2015.62.3488","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.6.1905.1905","article-title":"Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor","volume":"74","author":"Siena S","year":"1989","unstructured":"Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 1989, 74:1905-1914. 10.1182\/blood.V74.6.1905.1905","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92012-0","article-title":"Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man","volume":"1","author":"Socinski MA","year":"1988","unstructured":"Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet. 1988, 1:1194-1198. 10.1016\/S0140-6736(88)92012-0","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90795-5","article-title":"Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy","volume":"339","author":"Sheridan WP","year":"1992","unstructured":"Sheridan WP, Begley CG, Juttner CA, et al.. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992, 339:640-644. 10.1016\/0140-6736(92)90795-5","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2889","article-title":"Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant","volume":"141","author":"Afessa B","year":"2012","unstructured":"Afessa B, Abdulai RM, Kremers WK, Hogan WJ, Litzow MR, Peters SG. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest J. 2012, 141:442-450. 10.1378\/chest.10-2889","journal-title":"Chest J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky J","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, et al.. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016, 27:V111-V118. 10.1093\/annonc\/mdw325","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines","volume":"18","author":"Ozer H","year":"2000","unstructured":"Ozer H, Armitage JO, Bennett CL, et al.. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol. 2000, 18:3558-3585. 10.1200\/JCO.2000.18.20.3558","journal-title":"J Clin Oncol"},{"key":"ref10","unstructured":"Neupogen - FDA. Accessed. November 2020: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/103353s5184lbl.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.5.1695","article-title":"Granulocyte colonystimulating factor or neutrophil-induced pulmonary toxicity: myth or reality?","volume":"120","author":"Azoulay E","year":"2001","unstructured":"Azoulay E, Attalah H, Harf A, Schlemmer B, Delclaux C. Granulocyte colonystimulating factor or neutrophil-induced pulmonary toxicity: myth or reality?. Chest J. 2001, 120:1695-1701. 10.1378\/chest.120.5.1695","journal-title":"Chest J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000409","article-title":"Critically ill patient due to pneumonitis secondary to the use of filgrastim","volume":"23","author":"Vilaplana BE","year":"2016","unstructured":"Vilaplana BE, Guti\u00e9rrez JR, de Ibarguen BC, Manrique MM, Guerrero AS. Critically ill patient due to pneumonitis secondary to the use of filgrastim.  Am J Ther. 2016, 23:e1946-e1948. 10.1097\/MJT.0000000000000409","journal-title":"Am J Ther"},{"key":"ref13","unstructured":"Neupogen - Medscape. Accessed. November 2020: https:\/\/reference.medscape.com\/drug\/g-csf-neupogen-filgrastim-342164#5."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705037","article-title":"Respiratory status deterioration during G-CSF-induced neutropenia recovery","volume":"36","author":"Karlin L","year":"2005","unstructured":"Karlin L, Darmon M, Thi\u00e9ry G, et al.. Respiratory status deterioration during G-CSF-induced neutropenia recovery. Bone Marrow Transplant. 2005, 36:245-250. 10.1038\/sj.bmt.1705037","journal-title":"Bone Marrow Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45806-filgrastim-associated-pneumonitis-in-cancer-patient-undergoing-hematopoietic-stem-cell-hsc-mobilization-for-autologous-hsc-transplantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:22Z","timestamp":1707506722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45806-filgrastim-associated-pneumonitis-in-cancer-patient-undergoing-hematopoietic-stem-cell-hsc-mobilization-for-autologous-hsc-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.12114","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,16]]}}}